{"id":"https://openalex.org/W2139196448","doi":"https://doi.org/10.1017/s1461145706006602","title":"Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study","display_name":"Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study","publication_year":2006,"publication_date":"2006-03-30","ids":{"openalex":"https://openalex.org/W2139196448","doi":"https://doi.org/10.1017/s1461145706006602","mag":"2139196448","pmid":"https://pubmed.ncbi.nlm.nih.gov/16573847"},"language":"en","primary_location":{"id":"doi:10.1017/s1461145706006602","doi":"https://doi.org/10.1017/s1461145706006602","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145706006602","pdf_url":"https://academic.oup.com/ijnp/article-pdf/10/2/263/1854380/10-2-263.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/ijnp/article-pdf/10/2/263/1854380/10-2-263.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006614200","display_name":"Satoshi Asakura","orcid":"https://orcid.org/0000-0002-4317-3580","observed_orcids":["https://orcid.org/0000-0002-4317-3580","https://orcid.org/0009-0007-1297-8507"]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Satoshi Asakura","raw_affiliation_strings":["Health Administration Center and Department of Psychiatry, Hokkaido University School of Medicine, Sapporo, Hokkaido, Japan. asakurap@academic.hokudai.ac.jp","Health Administration Center and Department of Psychiatry, Hokkaido University School of Medicine, Sapporo, Hokkaido, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Administration Center and Department of Psychiatry, Hokkaido University School of Medicine, Sapporo, Hokkaido, Japan. asakurap@academic.hokudai.ac.jp","institution_ids":["https://openalex.org/I205349734"]},{"raw_affiliation_string":"Health Administration Center and Department of Psychiatry, Hokkaido University School of Medicine, Sapporo, Hokkaido, Japan","institution_ids":["https://openalex.org/I205349734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011851188","display_name":"O. Tajima","orcid":"https://orcid.org/0000-0003-2439-2611","observed_orcids":["https://orcid.org/0000-0003-2439-2611"]},"institutions":[{"id":"https://openalex.org/I190930483","display_name":"Kyorin University","ror":"https://ror.org/0188yz413","country_code":"JP","type":"education","lineage":["https://openalex.org/I190930483"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Osamu Tajima","raw_affiliation_strings":["Department of Mental Health, Kyorin University School of Health Science, Hachioji, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Mental Health, Kyorin University School of Health Science, Hachioji, Tokyo, Japan","institution_ids":["https://openalex.org/I190930483"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054302897","display_name":"Tsukasa Koyama","orcid":"https://orcid.org/0000-0002-8938-456X","observed_orcids":["https://orcid.org/0000-0002-8938-456X"]},"institutions":[{"id":"https://openalex.org/I205349734","display_name":"Hokkaido University","ror":"https://ror.org/02e16g702","country_code":"JP","type":"education","lineage":["https://openalex.org/I205349734"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsukasa Koyama","raw_affiliation_strings":["Department of Psychiatry, Hokkaido University School of Medicine, Sapporo, Hokkaido, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Hokkaido University School of Medicine, Sapporo, Hokkaido, Japan","institution_ids":["https://openalex.org/I205349734"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5006614200"],"corresponding_institution_ids":["https://openalex.org/I205349734"],"apc_list":{"value":2042,"currency":"GBP","value_usd":2693},"apc_paid":null,"fwci":5.0338,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.94447731,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"10","issue":"02","first_page":"263","last_page":"263"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/generalized-social-anxiety-disorder","display_name":"generalized social anxiety disorder","score":0.984000027179718},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.734000027179718},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.7160000205039978},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8360000252723694},{"id":"https://openalex.org/keywords/psychosocial-impairment","display_name":"psychosocial impairment","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.9603261947631836},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7817540168762207},{"id":"https://openalex.org/C2777545354","wikidata":"https://www.wikidata.org/wiki/Q3557657","display_name":"Social anxiety","level":3,"score":0.6945266723632812},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5462838411331177},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.543181836605072},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4781697392463684},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.46602463722229004},{"id":"https://openalex.org/C2776317618","wikidata":"https://www.wikidata.org/wiki/Q544006","display_name":"Anxiety disorder","level":3,"score":0.4582497477531433},{"id":"https://openalex.org/C202061045","wikidata":"https://www.wikidata.org/wiki/Q7200267","display_name":"Placebo-controlled study","level":5,"score":0.4409680664539337},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.4334961473941803},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.4325064420700073},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.42531338334083557},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3940221965312958},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36878323554992676},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.34307950735092163},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.19670304656028748},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.18239495158195496},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.12121319770812988},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017668","descriptor_name":"Age of Onset","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1017/s1461145706006602","doi":"https://doi.org/10.1017/s1461145706006602","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145706006602","pdf_url":"https://academic.oup.com/ijnp/article-pdf/10/2/263/1854380/10-2-263.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmid:16573847","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16573847","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The international journal of neuropsychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:irdb.nii.ac.jp:01364:0007154740","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/2115/33762","pdf_url":"https://eprints.lib.hokudai.ac.jp/repo/huscap/all/33762/S1461145706006602a.pdf","source":{"id":"https://openalex.org/S7407056385","display_name":"Institutional Repositories DataBase (IRDB)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I184597095","host_organization_name":"National Institute of Informatics","host_organization_lineage":["https://openalex.org/I184597095"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal article"},{"id":"pmh:oai:eprints.lib.hokudai.ac.jp:2115/33762","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2115/33762","pdf_url":null,"source":{"id":"https://openalex.org/S4306400549","display_name":"Hokkaido University Collection of Scholarly and Academic Papers (Hokkaido University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I205349734","host_organization_name":"Hokkaido University","host_organization_lineage":["https://openalex.org/I205349734"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1017/s1461145706006602","doi":"https://doi.org/10.1017/s1461145706006602","is_oa":true,"landing_page_url":"https://doi.org/10.1017/s1461145706006602","pdf_url":"https://academic.oup.com/ijnp/article-pdf/10/2/263/1854380/10-2-263.pdf","source":{"id":"https://openalex.org/S199972112","display_name":"The International Journal of Neuropsychopharmacology","issn_l":"1461-1457","issn":["1461-1457","1469-5111"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311647","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/P4310311647"],"host_organization_lineage_names":["University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The International Journal of Neuropsychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.5199999809265137,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139196448.pdf","grobid_xml":"https://content.openalex.org/works/W2139196448.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W559989846","https://openalex.org/W1969610924","https://openalex.org/W1971954042","https://openalex.org/W1994095895","https://openalex.org/W1995653279","https://openalex.org/W1998091136","https://openalex.org/W1999498090","https://openalex.org/W2004522378","https://openalex.org/W2014067009","https://openalex.org/W2016320303","https://openalex.org/W2021153010","https://openalex.org/W2026113991","https://openalex.org/W2044733363","https://openalex.org/W2046649654","https://openalex.org/W2050018668","https://openalex.org/W2052544510","https://openalex.org/W2053110423","https://openalex.org/W2065589549","https://openalex.org/W2080915014","https://openalex.org/W2081936550","https://openalex.org/W2088384703","https://openalex.org/W2093840588","https://openalex.org/W2121750660","https://openalex.org/W2135137329","https://openalex.org/W2135917232","https://openalex.org/W2136485882","https://openalex.org/W2147318064","https://openalex.org/W2159011576","https://openalex.org/W2159061031","https://openalex.org/W2168869947","https://openalex.org/W2169621217","https://openalex.org/W2247800712","https://openalex.org/W2346114762","https://openalex.org/W2625932592","https://openalex.org/W3090293687","https://openalex.org/W3144329766"],"related_works":["https://openalex.org/W2147318064","https://openalex.org/W2853077170","https://openalex.org/W1964315130","https://openalex.org/W2169621217","https://openalex.org/W1969610924","https://openalex.org/W2021153010","https://openalex.org/W2097111056","https://openalex.org/W2253389718","https://openalex.org/W2090715348","https://openalex.org/W2180149895"],"abstract_inverted_index":{"The":[0,100,121],"efficacy":[1,102,165],"of":[2,11,48,95,140,153,237],"selective":[3],"serotonin":[4],"reuptake":[5],"inhibitors":[6],"(SSRIs)":[7],"for":[8,50,65,76,163,234],"the":[9,20,44,110,128,141,164,170,179,199,214,235],"treatment":[10,71,80,236],"social":[12],"anxiety":[13],"disorder":[14],"(SAD)":[15],"has":[16,28],"been":[17,29],"reported":[18],"in":[19,33,54,178],"USA":[21],"and":[22,46,86,137,157,224],"Europe.":[23],"However,":[24],"no":[25],"clinical":[26],"investigation":[27],"done":[30],"with":[31,36,72,184,188,203,217,240],"SSRIs":[32],"Japanese":[34,55,116,238],"patients":[35,61,156,160,172,186,205,208,219,239],"SAD.":[37],"This":[38],"study":[39],"was":[40,81,104,222],"performed":[41],"to":[42,69,92,127,147],"determine":[43],"effectiveness":[45],"safety":[47],"fluvoxamine":[49,73,191,231],"generalized":[51],"SAD":[52],"(GSAD)":[53],"patients.":[56],"In":[57],"this":[58],"double-blind":[59],"study,":[60],"meeting":[62],"DSM-IV":[63],"criteria":[64],"GSAD":[66],"were":[67,124,161],"randomized":[68],"receive":[70],"or":[74,97],"placebo":[75],"10":[77],"wk.":[78],"Fluvoxamine":[79,221],"initiated":[82],"at":[83,194],"50":[84,89],"mg/d,":[85],"increased":[87],"by":[88],"mg":[90],"weekly":[91],"a":[93,174],"maximum":[94],"150":[96],"300":[98],"mg/d.":[99],"primary":[101],"outcome":[103],"mean":[105],"change":[106],"from":[107],"baseline":[108],"on":[109,198,213],"Liebowitz":[111],"Social":[112],"Anxiety":[113],"Scale":[114,144],"-":[115,132],"Version":[117],"(LSAS-J)":[118],"total":[119,152,181],"score.":[120],"secondary":[122],"outcomes":[123],"response":[125],"according":[126],"Clinical":[129],"Global":[130,133],"Impressions":[131],"Improvement":[134],"(CGI-I)":[135],"score":[136,182],"three":[138],"domains":[139],"Sheehan":[142],"Disability":[143],"(SDS;":[145],"used":[146],"assess":[148],"psychosocial":[149],"impairment).":[150],"A":[151],"176":[154],"fluvoxamine-treated":[155,171],"89":[158],"placebo-treated":[159,185,204,218],"eligible":[162],"analysis.":[166],"At":[167],"week":[168],"10,":[169],"had":[173,210],"significantly":[175,189],"greater":[176],"reduction":[177],"LSAS-J":[180],"compared":[183,202,216],"(p=0.0197),":[187],"more":[190],"recipients":[192],"being":[193],"least":[195],"much":[196],"improved":[197],"CGI-I":[200],"scale":[201],"(p=0.024).":[206],"Fluvoxamine-treated":[207],"also":[209],"better":[211],"responses":[212],"SDS":[215],"(p=0.0208).":[220],"safe":[223],"well":[225],"tolerated.":[226],"These":[227],"results":[228],"suggest":[229],"that":[230],"is":[232],"effective":[233],"GSAD.":[241]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}